Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effective Dose of Oliceridine for Hemodynamic Control During Intubation
NCT07154979Completed
- Start
- Sep 2025
- Primary completion
- Sep 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of oliceridine in hemodynamic instability. Primary endpoints: 95% Effective Dose of Oliceridine and 50% Effective Dose of Oliceridine. Started Sep 2025; status: completed.
02
Drugs
oliceridine
03
Conditions
hemodynamic instability
Beyond the preview
Go deeper on NCT07154979.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07154979.